摘要
Infliximab是一直接针对肿瘤坏死因子α(TNF-α)的嵌合性单克隆抗体,主要用于治疗克罗恩病及类风湿性关节炎。随着对其研究的加深,Infliximab在临床上的应用越来越广泛。本文就in-fliximab临床应用的进展作一综述。
Infliximab, an anti-TNF-αchimeric monoclonal antibody, is primarily used in the treatment for Crehn's disease and rheumatoid arthritis. Infliximab is widely used in clinic and beyond its original purposes after extensive investigation on this antibody. The recent progress of Infliximab used in clinic is reviewed in this paper.
出处
《医学综述》
2006年第5期293-295,共3页
Medical Recapitulate